Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

NanoViricides Inc. (NNVC)

Add NNVC Price Alert      Hide Sticky   Hide Intro
Moderator: Steady_T, NewMoney, drkazmd65
Search This Board: 
Last Post: 11/17/2017 9:02:49 PM - Followers: 464 - Board type: Free - Posts Today: 0

NanoViricides, Inc (NNVC)

Company Address:
135 Wood St, Suite 200
West Haven, CT 06516
Phone:  203-937-6137
Fax:  203-859-5095
CIK:  0001379006
NanoViricides, Inc. is a development stage company with a unique nanomedicine technology. The Company is developing nanotechnology-based biomimetic anti-viral medicines, that we call "nanoviricides®". 
A "nanoviricide" is an antiviral agent designed by the Company to fool a virus into attaching to this agent in the same way that the virus normally attaches to receptors on a cell surface. Once attached, the flexible nanoviricide glob would wrap around the virus and trap it. In the process, the virus could lose its coat proteins that it needs to bind to a cell. The virus is thus neutralized and effectively destroyed. Nanoviricides are designed to complete the task of dismantling the virus particle without immune system assistance.
Thus nanoviricides represent the next great advance in "Immunotherapeutics" (antibodies and vaccines,) the well established antiviral strategies. Viruses have developed smart strategies to derail immune system function. This results in failure of antibodies and vaccines.
The nanoviricide technology attempts to circumvent virus escape that results from natural changes in virus structure. Despite all such changes, the cell receptor to which a virus binds remains the same. Nanoviricides mimic this conserved feature of virus binding to its host cell receptor. If a virus "escapes" a properly designed nanoviricide, it would have a reduced ability to attach to the cell receptor and would have become much less pathogenic in the process.
Recent News:

Micrographic images of nanoviricide micelles in action against Murine Cytomegalovirus:

SEC Filings:
Share Structure:  See SEC filings for current share structure
Investor Relations:
Amanda Schuon, 310-550-7200


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NNVC News: Quarterly Report (10-q) 11/14/2017 05:25:18 PM
NNVC News: Revised Proxy Soliciting Materials (definitive) (defr14a) 11/08/2017 05:18:02 PM
NNVC News: NanoViricides Provides Further Details on Its Herpes-Induced Acute Retinal Necrosis Animal Study to be Presented On November ... 11/06/2017 07:00:00 AM
NNVC News: Excellent Results in Inhibiting Shingles Virus in Human Skin: NanoViricides Extends Agreement with SUNY Upstate Medical Cente... 10/26/2017 07:00:00 AM
NNVC News: NanoViricides to Present Results On Successful Treatment Of Herpes-Induced Acute Retinal Necrosis at the Annual Meeting of th... 10/17/2017 07:00:00 AM
#135391  Sticky Note NEWS -- NanoViricides to Present Results On Successful Paulness 10/17/17 08:32:35 AM
#135246  Sticky Note " The Company does not currently have a arvitar 10/06/17 08:49:18 PM
#136196   Closeness to self-inflicted financial pain? arvitar 11/17/17 09:02:49 PM
#136195   But it turns out that more useful information NewMoney 11/17/17 08:41:41 PM
#136194   Glad to see my comments followed so closely drkazmd65 11/17/17 08:23:54 PM
#136193   "On November 13, 2017, the Registrant entered into loanranger 11/17/17 08:08:35 PM
#136192   SUPERFICAILLY YES: +1 CENT ON Trendliner 11/17/17 06:53:02 PM
#136191   A big gamble,... or a bit of confidence? arvitar 11/17/17 05:47:03 PM
#136190   Here’s what really happened today. We had a NewMoney 11/17/17 04:54:42 PM
#136189   Looks as if someone bought 125,000 shares. Its_lose_not_loose 11/17/17 04:53:55 PM
#136188   Has absolutely no relevance to anything. Its_lose_not_loose 11/17/17 04:14:19 PM
#136184   Could you explain what this means? arvitar 11/17/17 03:21:23 PM
#136183   It is a close relative, though, and you Ubertino 11/17/17 03:20:09 PM
#136181   Glaxo, or anyone else interested in Diwan's aging arvitar 11/17/17 03:16:09 PM
#136180   Perhaps Glaxo will assist? Ubertino 11/17/17 03:12:52 PM
#136179   Not even close. arvitar 11/17/17 02:29:37 PM
#136178   No. My concern has been simply that this NewMoney 11/17/17 02:21:47 PM
#136176   The $5,000,000 from Boniuk should relieve those concerns somewhat. Ubertino 11/17/17 02:09:46 PM
#136175   Rarely is good news announced on Friday afternoon. Nanotoday 11/17/17 01:45:26 PM
#136174   So perhaps my 'false' statement is true. Its_lose_not_loose 11/17/17 01:41:36 PM
#136173   INTRADAY BUYING PRESSURE INCREASES Trendliner 11/17/17 01:28:56 PM
#136172   It apparently hasn't registered. arvitar 11/17/17 01:19:16 PM
#136170   We've been hearing thngs like this for 12, Its_lose_not_loose 11/17/17 12:51:35 PM
#136169   I think we have heard that a few mike41 11/17/17 12:44:52 PM
#136168   Stop making sense! Its_lose_not_loose 11/17/17 12:37:28 PM
#136167   Management believes that the Company’s existing cash resources arvitar 11/17/17 12:20:16 PM
#136166   Convinced and ready to rumble!! Ubertino 11/17/17 12:11:16 PM
#136163   Not sure, but I think someone just covered mike41 11/17/17 11:21:14 AM
#136162   uh oh mike41 11/17/17 11:11:27 AM
#136161   Prepare to descend deeper into the depths of NewMoney 11/17/17 10:08:00 AM
#136160   I hope you meant to write tar pit Nanotoday 11/17/17 10:06:30 AM
#136159   Bullshit. They have created nothing but rumors of NewMoney 11/17/17 10:05:50 AM
#136158   AT ONE TIME I DID HOLD A LOT Trendliner 11/17/17 09:59:05 AM
#136156   Furthermore, they haven't even selected a lead candidate, Its_lose_not_loose 11/17/17 09:48:54 AM
#136154   "In pharmacology, a pharmaceutical drug, also called a arvitar 11/17/17 09:41:31 AM
#136152   "God, am I glad I never took a loanranger 11/17/17 08:34:57 AM
#136151   They've created many drugs! Ubertino 11/17/17 08:13:55 AM
#136150   Is Your Board Carrying Out Its Fiduciary Duty??? Trendliner 11/17/17 08:05:55 AM
#136149   NNVC is a great company now and NewMoney 11/16/17 08:55:27 PM
#136148   There is no news of consequence other than arvitar 11/16/17 08:01:27 PM
#136147   It was just a guess. mike41 11/16/17 06:34:13 PM
#136146   Ansun BioPharma Announces Breakthrough Designation for its Experimental Ex Actuary 11/16/17 06:12:55 PM
#136145   Bad guess. Ex Actuary 11/16/17 06:07:52 PM
#136144   Management believes that the Company’s existing cash resources arvitar 11/16/17 02:30:29 PM
#136143   We'll have to agree to disagree about the Nanotoday 11/16/17 02:03:13 PM
#136142   I AGREE WITH KMBJN: NNVC DID NOT Trendliner 11/16/17 12:34:20 PM
#136141   Were the results already out when the announce Nanotoday 11/16/17 12:30:16 PM
#136140   I'm convinced! Ubertino 11/16/17 12:22:49 PM
#136139   Here’s my prediction. Tomorrow nothing significant will happen NewMoney 11/16/17 12:16:31 PM
#136138   It's too late for Dr. Boniuk to take KMBJN 11/16/17 12:14:05 PM